Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 25, 2022

Primary Completion Date

March 8, 2023

Study Completion Date

March 8, 2023

Conditions

Postoperative Depression

Interventions

DRUG

Ketamine

NMDA antagonist

DRUG

Normal saline

IV fluid acting as a placebo

Trial Locations (1)

Washington University School of Medicine, St Louis

All Listed Sponsors

lead

Washington University School of Medicine

OTHER